GE HealthCare (GEHC) Tops Q2 EPS by 2c, cuts revenue guidance
GE HealthCare (NASDAQ: GEHC) reported Q2 EPS of $1.00, $0.02 better than the analyst estimate of $0.98. Revenue for the quarter came in at $4.84 billion versus the consensus estimate of $4.87 billion.
The company sees full-year EPS between $4.20 and $4.35, in line with the consensus of $4.27.
Organic revenue growth in the range of 1% to 2% year-over-year versus the prior guide of approximately 4%, due to China market headwinds
For earnings history and earnings-related data on GE HealthCare (GEHC) click here.